MEL - Melanoma Back

External References: Wikipedia National Cancer Institute Google Scholar

iCoMut Beta for


Highly significantly mutated genes
BRAF
75 patients (63%)
NRAS
28 patients (23%)
BCLAF1
22 patients (18%)
TP53
21 patients (17%)
CDKN2A
18 patients (15%)
RAC1
5 patients (4%)
Significantly mutated genes
XIRP2
22 patients (18%)
MYOCD
18 patients (15%)
ALPK2
17 patients (14%)
PTEN
11 patients (9%)
PPP6C
11 patients (9%)
FRMD7
10 patients (8%)
OR4A16
10 patients (8%)
OR52N1
8 patients (6%)
WASF3
8 patients (6%)
CDK4
5 patients (4%)
LCTL
5 patients (4%)
STK19
4 patients (3%)
ACO1
4 patients (3%)
Genes near significance
ANK3
44 patients (37%)
MXRA5
33 patients (27%)
GPR116
13 patients (11%)
SLC12A8
10 patients (8%)
EGFL6
9 patients (7%)
PCDP1
9 patients (7%)
ARID2
9 patients (7%)
CCDC148
8 patients (6%)
SNX31
8 patients (6%)
SLC44A4
8 patients (6%)
CTNNB1
8 patients (6%)
MGC42105
7 patients (5%)
ZNF217
7 patients (5%)
RXRA
6 patients (5%)
NCOR1
6 patients (5%)
ALDH1B1
5 patients (4%)
ZNF750
5 patients (4%)
PIK3CA
5 patients (4%)
FDXACB1
4 patients (3%)
KIT
4 patients (3%)
Click on a gene to see details.

Notes


• Gene name color indicates: known cancer genes | highly compelling novel candidate cancer genes | other candidates

Data details


Mutation list for MEL
Q-Q plots for MEL